Abstract
From January to December 2011, 24 Pseudomonas aeruginosa strains producing the extended-spectrum β-lactamase SHV-2a were identified in 13 hospitals in France. With one exception, all the strains belonged to the same clone. Double-disk synergy tests with cefepime and clavulanate were able to detect all the SHV-2a-positive isolates.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Typing Techniques
-
Cross Infection / epidemiology
-
Cross Infection / microbiology*
-
France / epidemiology
-
Hospitals
-
Humans
-
Microbial Sensitivity Tests
-
Pseudomonas Infections / epidemiology
-
Pseudomonas Infections / microbiology*
-
Pseudomonas aeruginosa / classification*
-
Pseudomonas aeruginosa / drug effects
-
Pseudomonas aeruginosa / genetics
-
beta-Lactamases / biosynthesis*
-
beta-Lactamases / genetics
Substances
-
Anti-Bacterial Agents
-
beta-lactamase SHV-12
-
beta-lactamase SHV-2a
-
beta-Lactamases